长荣股份(300195) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was CNY 339,679,055.70, a decrease of 0.72% compared to CNY 342,129,866.77 in the same period last year[5] - Net profit attributable to shareholders increased by 64.53% to CNY 4,584,640.35 from CNY 2,786,555.55 year-on-year[5] - The net profit after deducting non-recurring gains and losses surged by 601.81% to CNY 3,672,855.20, compared to a loss of CNY 731,922.60 in the previous year[5] - Basic earnings per share rose by 8.00% to CNY 0.0108, compared to CNY 0.01 in the previous year[5] - Total operating revenue for Q1 2025 was CNY 339,679,055.70, a decrease of 1.3% from CNY 342,129,866.77 in the previous period[18] - Net profit for the period was CNY 3,106,974.87, compared to CNY 1,352,769.92 in the previous period, representing a significant increase of 129.0%[19] - The profit attributable to shareholders of CNY 4,584,640.35, up from CNY 2,786,555.55, marking a growth of 64.4%[19] Cash Flow and Liquidity - Operating cash flow increased by 85.31% to CNY 15,087,938.71, up from CNY 8,142,070.64 in the same period last year[5] - The company's cash flow from operating activities showed improvement, contributing positively to the overall financial health[20] - Operating cash inflow totaled $507.23 million, a decrease of 14.8% from $595.38 million in the previous period[21] - Operating cash outflow amounted to $492.14 million, down from $587.24 million, resulting in a net cash flow from operating activities of $15.09 million, an increase of 85.5% from $8.14 million[21] - Financing cash inflow was $340.84 million, significantly lower than $690.50 million in the prior period[22] - Financing cash outflow totaled $334.77 million, down from $751.47 million, resulting in a net cash flow from financing activities of $6.07 million, a turnaround from -$60.97 million[22] - The net increase in cash and cash equivalents was -$38.10 million, an improvement from -$91.11 million in the previous period[22] - The ending balance of cash and cash equivalents stood at $164.29 million, up from $94.89 million[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 6,236,826,002.77, a slight decrease of 0.01% from CNY 6,237,200,068.27 at the end of the previous year[5] - Total liabilities decreased to CNY 3,385,234,445.58 from CNY 3,389,747,998.19, a reduction of 0.1%[17] - The company reported a total current assets of CNY 2,288,796,462.05 as of March 31, 2025, showing a slight increase from CNY 2,285,385,698.89 at the beginning of the period[15] - Cash and cash equivalents decreased to CNY 263,119,630.83 from CNY 286,036,130.52, indicating a decline of approximately 8.0%[15] - Accounts receivable stood at CNY 350,341,831.17, a minor decrease from CNY 354,828,585.38, reflecting a reduction of about 1.4%[15] - Inventory increased to CNY 890,442,489.78 from CNY 865,505,761.32, representing a growth of approximately 2.9%[15] - Long-term equity investments amounted to CNY 345,331,233.94, slightly up from CNY 342,813,699.03, indicating an increase of about 0.4%[15] - The company’s fixed assets decreased to CNY 1,072,258,771.79 from CNY 1,096,805,878.77, reflecting a decline of approximately 2.2%[15] Operational Efficiency - The company’s financial expenses decreased by 54.72% to CNY 815.07 million, primarily due to increased exchange gains from foreign currency appreciation[9] - The net cash flow from financing activities improved by 109.95% to CNY 606.81 million, compared to a net outflow of CNY 6,096.68 million in the previous year[9] - The company’s total liabilities and equity structure remains stable, with a focus on maintaining liquidity and operational efficiency[15] - The management indicated a commitment to improving operational metrics and financial performance through strategic investments and cost management[15] Strategic Initiatives - The company is exploring new market expansion strategies and product development initiatives to enhance growth prospects in the upcoming quarters[15] - The company continues to focus on market expansion and new product development strategies to drive future growth[20] - Research and development expenses were CNY 13,883,337.95, down from CNY 16,014,660.56, indicating a decrease of 13.3%[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,076[11] - The company did not undergo an audit for the first quarter report[23]